EarlyCDT Lung

EarlyCDT Lung is a test for the levels of seven autoantibodies to tumour-associated antigens to help improve the detection of lung cancer.

It was created by Oncimmune and Eastern AHSN is looking at supporting a project in primary care across parts of the region.  

EarlyCDT Lung is a simple blood test that detects the elevated presence of autoantibodies generated by the body’s immune system as a natural defence against cancer cells. 

EarlyCDT wacreated by Oncimmune and Eastern AHSN is looking at supporting a project in primary care across parts of the region.  

Oncimmune lab bench

Find out more about EarlyCDT Lung

Oncimmune article - Early CDT
Impact review

There’s more information about EarlyCDT Lung and how we have supported Oncimmune in our latest impact review article on cancer.

Read more

Get in touch

Katrina Wilson Eastern AHSN

To learn more about our projects to detect and treat cancer contact [email protected]

Visit the website

Find out more about EarlyCDT Lung and Oncimmune visit oncimmune.com

Share your idea

Do you have a great idea that could make a positive health impact?

Get involved

Newsletter